Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.

Allan Relecom, Massimo Federico, Joseph M Connors, Bertrand Coiffier, Irene Biasoli, Alden Moccia, Gilles Salles, Thomas McKee, Raymond Miralbell, Peter Borchmann, John Kuruvilla, Peter Johnson, Franco Cavalli, Martine Delavy, Pierre-Yves Dietrich, Antoine Flahault

Journal: International journal of environmental research and public health 2020;17(5):1783

PMID: 32182952

Free Full Text on MDPI View on PubMed

Abstract

Hodgkin lymphoma is a haematological malignancy predominantly affecting young adults. Hodgkin lymphoma is a highly curable disease by current treatment standards. Latest treatment guidelines for Hodgkin lymphoma however imply access to diagnostic and treatment modalities that may not be available in settings with restricted healthcare resources. Considerable discrepancies in Hodgkin lymphoma patient survival exist, with poorer outcomes reported in resources-constrained settings. Resources-stratified guidelines for diagnosis, staging and treatment of Hodgkin lymphoma were derived in an effort to optimize patient outcome provided a given setting of available resources. These guidelines were derived based on the framework of the Breast Health Global Initiative stratifying resource levels in basic, core, advanced and maximal categories.

Address: Department of Oncology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland.; Medical Oncology, CHIMOMO Department, University of Modena and Reggio Emilia, Via Università 4, 41121 Modena, Italy.; BC Cancer Agency, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 1G1, Canada.; Department of Hematology, Hospices Civils de Lyon, 3 Quai des Celestins, 69002 Lyon, France.; Internal Medicine Department, Federal Univsersity of Rio de Janeiro, Av. Pedro Calmon, 550-Cidade Universitária-Rio de Janeiro, RJ 21941-901, Brazil.; Oncology Institute of Southern Switzerland (IOSI) Ospedale Regionale di Locarno "La Carità", Via Ospedale 1 CH-6600 Locarno.; Groupe d'étude des lymphomes de l'adulte, CHU de Lyon HCL-GH Sud, 165 Chemin du Grand Revoyet, 69495 Pierre-Benite Cedex, France.; Clinical Pathology Unit, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva Switzerland.; Faculté de Médecine, Geneva University, Rue Michel-Servet 1, 1206 Genève, Switzerland.; Department of Internal Medicine, University Hospital of Cologne, Karpener Str 62, 50924 Cologne, Germany.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 2C1, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.; Faculty of Medicine, University of Southampton, Southampton S017 1BJ, UK.; Institute of Oncology Research (IOR), Via Vela 6, 6500 Bellinzona, Switzerland.; Institute of Global Health, Faculty of Medicine, University of Geneva, Campus Biotech, Chemin des Mines 9, 1202 Geneva, Switzerland.

DOI: 10.3390/ijerph17051783

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/hodgkinlymphoma.html

MeSH Terms: Guidelines as Topic, Health Resources, Hodgkin Disease, Humans